Detalles de la búsqueda
1.
Decitabine in Older Patients with AML: Quality of Life Results of the EORTC-GIMEMA-GMDS-SG Randomized Phase III Trial.
Blood
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38717861
2.
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
Ann Hematol
; 99(7): 1551-1560, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32504186
3.
Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcome.
Haematologica
; 104(1): 59-69, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171030
4.
Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.
Genes Chromosomes Cancer
; 56(7): 524-534, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28236351
5.
Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5-aza-2'-deoxycytidine (Decitabine).
Br J Haematol
; 176(4): 609-617, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27905102
6.
Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.
Haematologica
; 102(2): 320-326, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27658438
7.
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.
Ann Hematol
; 95(2): 191-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26596971
8.
Distinct bone marrow morphologic features discriminate myelodysplastic syndromes patients with and without an early platelet response to decitabine.
Br J Haematol
; 189(5): e194-e197, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32207144
9.
Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology.
Haematologica
; 100(5): 677-82, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25661441
10.
Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG).
Ann Hematol
; 94(12): 2003-13, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26400023
11.
IMWG consensus on maintenance therapy in multiple myeloma.
Blood
; 119(13): 3003-15, 2012 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22271445
12.
Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK).
Blood
; 120(24): 4706-11, 2012 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-23047822
13.
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.
Haematologica
; 99(1): 148-54, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23996482
14.
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study.
Am J Hematol
; 89(4): 355-62, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24273190
15.
The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.
J Clin Apher
; 29(3): 133-8, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24130064
16.
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.
Br J Haematol
; 161(3): 357-66, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23432640
17.
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.
Blood
; 118(5): 1239-47, 2011 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-21670471
18.
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients.
Blood
; 117(11): 3025-31, 2011 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-21228328
19.
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.
Haematologica
; 98(2): 208-16, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22875615
20.
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.
Haematologica
; 98(6): 980-7, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23445873